Clinical Trials in North Carolina

Showing 18301-18320 of 20,428 trials

Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphoma

NCT00006345

RATIONALE: Denileukin diftitox may be able to deliver cancer-killing substances directly to T-cell lymphoma cells. Dexamethasone may decrease the side effects of denileukin diftitox. PURPOSE: Phase II trial to study the effectiveness of dexamethasone in preventing side effects following treatment with denileukin diftitox in treating patients who have persistent or recurrent T-cell lymphoma.

Drug/Agent Toxicity by Tissue/OrganLymphoma

Ligand PharmaceuticalsStarted Nov 1999

Miami, Florida, United States • Chicago, Illinois, United States • New Orleans, Louisiana, United States +8 more locations

COMPLETEDPhase 341 miles

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)

NCT00943072

This is a phase 3 study to determine the efficacy of VEGF Trap-Eye injected into the eye on vision function in subjects with macular edema as a consequence of central retinal vein occlusion.

Macular Edema Secondary to Central Retinal Vein Occlusion

Regeneron Pharmaceuticals189 participantsStarted Jul 2009

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +58 more locations

Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphoma

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)

Find Trials by Condition in North Carolina

Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer

Quality of Life in Survivors of Gynecologic Cancer

Single Injection of REGN475/SAR164877 in the Treatment of Chronic Pancreatitis Pain

Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer

Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Factors Affecting Adherence to Anti-HIV Drug Regimens in Children and Adolescents

A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.

Fecal Biomarker Study for Patients With Ulcerative Colitis

SWOG-9245 Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial

Stress Management Training in Patients Undergoing Radiation Therapy for Cancer

Study of the Safety and Tolerability of PCI-32765 in Patients With Recurrent B Cell Lymphoma

Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2

Clinical Efficacy Study Comparing VisionScope Imaging (VSI) to Magnetic Resonance Imaging (MRI) in Injuries of the Knee

Sorafenib/Docetaxel Dose Escalation Trial

Pilot Study Evaluating the Safety and Performance of the GeNO NITROsyl Delivery System for Inhaled Nitric Oxide

Study of the Safety and Pharmacokinetics of XL765 (SAR245409) in Adults With Solid Tumors

Study of MDX-1342 in Patients With Chronic Lymphocytic Leukemia (CLL)